Next Step After Positive Fecal Occult Blood Test (FOBT)

Rationale for Colonoscopy Follow-up

• The American Cancer Society recommends colonoscopy as the definitive follow-up test after a positive FOBT, allowing for direct visualization of the entire colon and providing the opportunity to identify and remove adenomatous polyps or detect colorectal cancer at an early stage 1, 2
• Inappropriate follow-up practices, such as repeating the FOBT or using flexible sigmoidoscopy alone, are not recommended as they may miss significant proximal lesions 3, 4
• Studies have shown that nearly one-third of physicians inappropriately repeat FOBT after a positive result instead of proceeding directly to colonoscopy, highlighting the need for improved follow-up practices 3

Timing of Colonoscopy

• The American Cancer Society recommends that colonoscopy should be performed within 60 days of a positive FOBT result to minimize the risk of disease progression 2
• Delays in follow-up colonoscopy are associated with increased risk of advanced colorectal cancer and poorer outcomes, emphasizing the importance of timely evaluation 2

Common Pitfalls in FOBT Follow-up

• Repeating the FOBT after a positive result is inappropriate and delays proper diagnostic evaluation, according to the American Cancer Society 3, 4
• Following up with flexible sigmoidoscopy alone is inadequate as it only visualizes the distal portion of the colon, and may miss significant lesions 5, 6

Quality Considerations

• Single-sample in-office FOBT collected during digital rectal examination has extremely poor sensitivity (only 4.9% for advanced neoplasia) and should not be used for screening, as stated by the American Cancer Society 7, 3

Improving Follow-up Rates

• Clear communication with patients about the importance of follow-up colonoscopy is essential for improving compliance, according to the American Cancer Society 2

Follow-up Procedures After a Positive Fecal Occult Blood Test (FOBT)

Timing and Risks of Delayed Colonoscopy

• Delays in follow-up colonoscopy beyond 180 days are associated with increased risk of colorectal cancer in a dose-response fashion, becoming statistically significant after 270 days (OR: 1.48, CI 1.05-2.08) 8
• Each additional month of delay in diagnostic colonoscopy is estimated to increase both CRC incidence and mortality by 0.1 per 1,000 (a 0.3% and 1.4% monthly increase) 8
• A 12-month delay is estimated to increase CRC incidence by 4% and mortality by 16% 8
• Empirical evidence shows increased risk for CRC incidence and higher stage disease with wait-times over 180 days 8

Alternative Diagnostic Tests

• CT colonography (CTC) can be considered if colonoscopy cannot be performed, with a per-patient sensitivity of 88.8% for ≥6-mm adenomas or colorectal cancer in FOBT-positive patients 9
• Double-contrast barium enema (DCBE) is less sensitive than CTC but can be used if CTC is not available, with sensitivity of 75% to 80% for detecting colorectal cancer in FOBT-positive patients 9

Proper FOBT Testing Procedures

• FOBT must be performed properly with 3 stool samples obtained at home 10
• A single-stool sample FOBT collected after digital rectal exam in the office is not an acceptable screening test 10
• Prior to testing with guaiac-based tests, individuals should avoid NSAIDs and high-dose aspirin for 7 days 10
• Dietary restrictions include avoidance of vitamin C in excess of 250 mg and red meats for 3 days before testing 10

Management of Positive Fecal Occult Blood Test Results

Definitive Follow-Up Test

• The American Gastroenterological Association recommends colonoscopy as the only follow-up test for a positive FOBT in screen-eligible individuals, due to its ability to directly visualize the entire colorectal mucosa and remove significant neoplasia, with a high positive predictive value for significant neoplasia 11

Special Circumstances

• For patients with a recent prior colonoscopy (within 5 years before being due for repeat examination), the American Gastroenterological Association generally still recommends repeat colonoscopy, considering clinical context, patient risk factors, and prior colonoscopy quality 11
• The American Gastroenterological Association notes that only 1% of guaiac FOBT-positive individuals with negative colonoscopy within the past 5 years were found to have advanced neoplasia, informing the decision to repeat colonoscopy 11

Management of Positive Fecal Occult Blood Test (FOBT)

Definitive Follow‑Up Test

• Colonoscopy is the only appropriate follow‑up test after a positive FOBT because it provides complete visualization of the colon and enables removal of adenomatous polyps or early detection of colorectal cancer. 12

Guideline Endorsements

• The American Cancer Society and the American Gastroenterological Association explicitly recommend colonoscopy as the definitive diagnostic procedure following any positive FOBT result. 12

Timing of Colonoscopy

• Colonoscopy should be scheduled and completed within 60 days of a positive FOBT to minimize the risk of disease progression. 12

Inadequacy of Flexible Sigmoidoscopy

• Flexible sigmoidoscopy alone is insufficient for a positive FOBT because it examines only the distal colon and can miss clinically significant proximal lesions; therefore, full colon evaluation is required. 12

Alternative Imaging When Colonoscopy Is Not Feasible

• If colonoscopy cannot be performed, CT colonography or double‑contrast barium enema may be used, but any positive finding on these alternative tests must be followed by endoscopic evaluation when possible. 12

Timing of Colonoscopy After a Positive Fecal Occult Blood Test

Risk Associated with a Positive FOBT

• A positive fecal occult blood test indicates roughly a 10 % probability of colorectal cancer and a 37 % probability of detecting a colonic polyp, underscoring the need for complete colonic evaluation. 13

Impact of Delayed Colonoscopy

• Colonoscopy should be performed within 60 days of a positive FOBT result to minimize the risk of disease progression. 14
• Delaying colonoscopy beyond 180 days is linked to a higher risk of colorectal cancer in a dose‑response manner, becoming statistically significant after 270 days (odds ratio = 1.48; 95 % CI = 1.05–2.08). 14
• Each additional month of postponement raises colorectal cancer incidence by 0.1 per 1,000 individuals (approximately a 0.3 % monthly increase) and mortality by 0.1 per 1,000 (approximately a 1.4 % monthly increase). 14
• A 12‑month delay in colonoscopy is associated with a 4 % increase in colorectal cancer incidence and a 16 % increase in mortality. 14